G.J. Creemers - Concepedia

Author

G.J. Creemers

Also Known As

G J Creemers, G J M Creemers, G-J Creemers, G. J. Creemers, G. J. M. Creemers, G.-J. Creemers, G.-J. M. Creemers, G.-J.M. Creemers, G.J. Creemers, G.J.M. Creemers

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Catharina Ziekenhuis Netherlands Comprehensive Cancer Organisation Erasmus MC The Netherlands Cancer Institute

About

G.J. Creemers is an author at Radboud University Nijmegen specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	1.2K
2	Gastroenterology	3	3	168
3	Health Sciences	1	1	44
4	Public Health	1	1	159
5	Epidemiology	1	1	159

G.J. Creemers

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, New England Journal of Medicine	2012	5.3K
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents J. Tol, Miriam Koopman, Michael Craig Miller, Annals of Oncology Overall SurvivalMedicinePathologyColorectal CancerTumour Cells	2009	212
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands Anneriet E. Dassen, V.E.P.P. Lemmens, Lonneke V. van de Poll‐Franse, European Journal of Cancer EpidemiologyPopulation-based StudyCancer EpidemiologyGastrointestinal OncologyMedicine	2010	159
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor JHM Schellens, G.J. Creemers, Hilde Rosing, British Journal of Cancer New TopoisomerasePharmacologyPharmacotherapyAnti-cancer AgentDrug Development	1996	130
Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study Robin J. Lurvink, Checca Bakkers, Anouk Rijken, European Journal of Surgical Oncology Metachronous Peritoneal MetastasesSurgical OncologyGastrointestinal OncologyMedicineColorectal Cancer	2020	88
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen, Annals of Oncology	2017	81
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study Kaitlyn K.H. Goey, Sjoerd G. Elias, Harm van Tinteren, Annals of Oncology Gastrointestinal OncologyMedicinePharmacologyPathologyColorectal Cancer	2017	78
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors. G.J. Creemers, C J Gerrits, John R. Eckardt, Journal of Clinical Oncology	1997	75
Feasibility of reirradiation in the treatment of locally recurrent rectal cancer S. Bosman, Fabian A. Holman, Grard A. P. Nieuwenhuijzen, British journal of surgery	2014	67
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands Lieke G.E.M. Razenberg, Yvette R.B.M. van Gestel, G.J. Creemers, European Journal of Surgical Oncology Cytoreductive SurgerySurgical OncologyGastrointestinal OncologyColorectal SurgeryMedicine	2015	66

Page 1